Does vedolizumab Therapy be Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases?
Both vedolizumab and anti-TNF biologic therapies were associated with improvement in sleep and mood quality in IBD.
Our results suggest that patient comfort is better during the first SWL session than in the following sessions for renal or ureteral stones with a stone burden of less than 100 mm(2). In addition, severity of pain during SWL treatment may be better tolerated in males than in females.